major histocompatibility complex (mhc)
91Antigen processing — is a biological process that prepares antigens for presentation to special cells of the immune system called T lymphocytes. This process involves two distinct pathways for processing of antigens from an organism s own (self) proteins or… …
92List of AIDS-related topics — This is a list of AIDS related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS Related Terms, 4th Edition. [http://www.aidsinfo.nih.gov/ed resources/glossary/] NOTOC A AACTG… …
93Rheumatoid arthritis — Classification and external resources A hand affected by rheumatoid arthritis ICD 10 M …
94Inclusion body myositis — Classification and external resources ICD 10 M60.8 [1] ICD 9 …
95Lipid raft — organisation, region (1) is standard lipid bilayer, while region (2) is a lipid raft. The plasma membrane of cells is made of a combination of glycosphingolipids and protein receptors organized in glycolipoprotein microdomains termed lipid… …
96Snell , George Davis — (1903–1996) American geneticist Snell was born in Bradford, Massachusetts, and educated at Dartmouth and Harvard, where he obtained his doctorate in 1930. After brief appointments at Texas, Brown, and Washington University, St. Louis, he joined… …
97Psoriasis — Classification and external resources A person whose back and arms are affected by psoriasis ICD 10 L …
98Molecular mimicry — is defined as the theoretical possibility that sequence similarities between foreign and self peptides are sufficient to result in the cross activation of autoreactive T or B cells by pathogen derived peptides. Despite the promiscuity of several… …
99Regulatory T cell — Regulatory T cells (sometimes known as suppressor T cells) are a specialized subpopulation of T cells that act to suppress activation of the immune system and thereby maintain immune system homeostasis and tolerance to self antigens. The… …
100Oncoantigen — An oncoantigen is a surface or soluble tumor antigen that supports tumor growth[1]. A major problem of cancer immunotherapy is the selection of tumor cell variants that escape immune recognition. The notion of oncoantigen was set forth in the… …
